United States Hospital Infectious Disease Testing Market 2016-2026: Emerging Opportunities and Growth Strategies for Suppliers

DUBLIN, Nov. 4, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/fpmn9t/2016_us_hospital) has announced the addition of the "2016 US Hospital Infectious Disease Testing Market: Emerging Opportunities and Growth Strategies for Suppliers" report to their offering.

This new report contains 997 pages, 87 tables, and presents a comprehensive analysis of the US hospital infectious disease testing market, including:

• Major issues pertaining to the US hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years
• Current scientific views on definition, epidemiology, and etiology of major infectious diseases and microorganisms
• Volume and sales forecasts for 80 infectious disease tests performed in US hospital laboratories
• Instrumentation technologies and feature comparison of leading analyzers
• Sales and market shares of leading suppliers by test
• Emerging diagnostic technologies and their potential market applications
• Product development opportunities
• Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies
• Business opportunities and strategic recommendations for suppliers

 Companies Mentioned

• Abbott
• Affymetrix
• Beckman Coulter/Danaher
• Becton Dickinson
• bioMerieux
• Bio-Rad
• Cepheid
• Diamedix
• DiaSorin
• Eiken Chemical
• Elitech Group
• Enzo Biochem
• Fujirebio
• Grifols
• Hologic/Gen-Probe
• ID Biomedical/GSK
• Kreat

For more information visit http://www.researchandmarkets.com/research/fpmn9t/2016_us_hospital

Media Contact:

Laura Wood, +353-1-481-1716, press@researchandmarkets.net

Related Links

http://www.researchandmarkets.com